Sol-Gel Technologies Ltd. (SLGL) Financials

SLGL Assets vs Liabilities

DateAssetsLiabilities
June 30, 2026 53.8 million 5.7 million
March 31, 2026 58.6 million 7.1 million
Dec. 31, 2025 29.9 million 7.1 million
Sept. 30, 2025 34.6 million 8.6 million

SLGL Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 ? ?
March 31, 2026 ? ?
Dec. 31, 2025 ? ?
Sept. 30, 2025 ? ?

SLGL Net Income

No data available :(

SLGL Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 47.9 million - 251000
March 31, 2026 52.8 million - 862000
Dec. 31, 2025 24.0 million - 496000
Sept. 30, 2025 20.8 million - 592000

SLGL Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 3.3 million
March 31, 2026 2.8 million
Dec. 31, 2025 2.8 million
Sept. 30, 2025 2.8 million

SLGL Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 3.7 million 1.0 million -
March 31, 2026 - 2.8 million 1.2 million -
Dec. 31, 2025 - 3.6 million 577000 -
Sept. 30, 2025 - 5.7 million 957000 -

SLGL Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 591000 -
March 31, 2026 108000 -
Dec. 31, 2025 696000 -
Sept. 30, 2025 400000 -

SLGL Revenue by Segment

Graph available only for paid members. Upgrade to see it.

SLGL

Price: $65.91

52 week price:
28.81
97.97

Earnings Per Share: -5.62 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: Israel

Volume: 22900

Market Capitalization: 235.4 million

Links: